STOCKWATCH
·
Pharmaceuticals
Quarterly Result4 May 2026, 03:52 pm

Wockhardt Reports ₹238 Cr Positive PBT for FY26

AI Summary

Wockhardt Ltd reported a positive Profit Before Tax (PBT) of ₹238 Cr for FY26, a significant improvement from a loss of ₹16 Cr in the previous year. The company's Q4 FY26 revenue grew by 30% to ₹965 crore, with EBITDA up by 147% to ₹196 Cr. For the full year, revenue increased by 11% to ₹3373 crore, and EBITDA grew by 51% to ₹630 Cr. Biosimilar operations showed strong growth, with a 126% increase in Q4 and 27% for the full year. India branded business grew by 18% in Q4 and 15% for the full year.

Key Highlights

  • FY26 PBT at ₹238 Cr vs. ₹(-)16 Cr in FY25.
  • Q4 FY26 revenue up 30% to ₹965 Cr.
  • FY26 revenue up 11% to ₹3373 Cr.
  • Biosimilar operations grew 126% in Q4 FY26.
  • India branded business grew 18% in Q4 FY26.
View BSE Filing